Stefan H. Hohnloser
Stefan H. Hohnloser
Director in the Division of Clinical Electrophysiology. J.W Goethe University in Frankfurt, Germany
Dr Hohnloser holds a position as Director, Division of Clinical Electrophysiology, J. W. Goethe University Frankfurt, Germany.
Dr Hohnloser completed his education at the University of Freiburg, Germany. In 1980, he was appointed Research Assistant in the Department of Physiology of that university for two years. From 1984 to 1985, he held the position of Research Assistant at the Harvard School of Public Health, and Brigham and Women's Hospital, Boston, USA. From 1986 to 1995, he worked at the university hospital in Freiburg where he finished his training in internal medicine and cardiology. Since 1995, he has served as a Professor of Medicine and Cardiology at the J. W. Goethe University, Frankfurt. In 2002, Dr Hohnloser was promoted to Director of the Division of Clinical Electrophysiology at the same university.
Dr Hohnloser is a fellow of numerous institutions including the American College of Cardiology (ACC), the European Society of Cardiology (ESC), the Heart Rhythm Society (HRS), and the German Society of Cardiology (GSC).
Dr Hohnloser has authored more than 250 articles in peer-reviewed journals and more than 40 book chapters. He is also a reviewer for the New England Journal of Medicine (NJEM), The Lancet, the Journal of the American Medical Association (JAMA), Circulation, the Journal of the American College of Cardiology (ACC), the Journal of Cardiovascular Electrophysiology, Heart Rhythm, American Journal of Physiology, American Journal of Cardiology, European Heart Journal (EHJ), American Heart Journal (AHJ), Pace and the Journal of Electrocardiography.
Dr Hohnloser’s main research interests are sudden cardiac death, risk stratification for sudden death, device therapy of life-threatening arrhythmias and pharmacological/non-pharmacological therapy of atrial fibrillation.
Director in the Division of Clinical Electrophysiology. J.W Goethe University in Frankfurt, Germany
Dr Hohnloser holds a position as Director, Division of Clinical Electrophysiology, J. W. Goethe University Frankfurt, Germany.Dr Hohnloser completed his education at the University of Freiburg, Germany. In 1980, he was appointed Research Assistant in the Department of Physiology of that university for two years. From 1984 to 1985, he held the position of Research Assistant at the Harvard School of Public Health, and Brigham and Women's Hospital, Boston, USA. From 1986 to 1995, he worked at the university hospital in Freiburg where he finished his training in internal medicine and cardiology. Since 1995, he has served as a Professor of Medicine and Cardiology at the J. W. Goethe University, Frankfurt. In 2002, Dr Hohnloser was promoted to Director of the Division of Clinical Electrophysiology at the same university.
Dr Hohnloser is a fellow of numerous institutions including the American College of Cardiology (ACC), the European Society of Cardiology (ESC), the Heart Rhythm Society (HRS), and the German Society of Cardiology (GSC).
Dr Hohnloser has authored more than 250 articles in peer-reviewed journals and more than 40 book chapters. He is also a reviewer for the New England Journal of Medicine (NJEM), The Lancet, the Journal of the American Medical Association (JAMA), Circulation, the Journal of the American College of Cardiology (ACC), the Journal of Cardiovascular Electrophysiology, Heart Rhythm, American Journal of Physiology, American Journal of Cardiology, European Heart Journal (EHJ), American Heart Journal (AHJ), Pace and the Journal of Electrocardiography.
Dr Hohnloser’s main research interests are sudden cardiac death, risk stratification for sudden death, device therapy of life-threatening arrhythmias and pharmacological/non-pharmacological therapy of atrial fibrillation.
- AF and its Management
- AF Facts and Figures
- Dronedarone (Multaq®) A new advance in the management of atrial fibrillation
- Dronedarone Clinical Trial Programme and Clinical Evidence
- Sanofi-aventis commitment and dedication in atrial fibrillation
- Speakers biographies
- Stroke-Risk Reduction in AF
- The ATHENA Study - Addressing the cardiovascular complications of atrial fibrillation
- Record AF
Latest videos
Latest Congress Announcement
ESC Congress 2011
This year, ESC Congress goes to Paris. The event is the year’s “Rendez-vous” for everybody involved in Cardiovascular Medicine, from clinical practitioners to basic scientists, epidemiologists, nurses, technicians, health care industry, opinion leaders and policy makers from around the world.
Paris, France.
Paris, France.

